Eaton Vance Management Atri Cure, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$35.1 - $66.01 $108,669 - $204,366	-3,096 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.43 - $71.39 $57 - $71	1 Added 0.03%	3,096 $203,000
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $2,009 - $2,449	-29 Reduced 0.93%	3,095 $215,000
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $17,764 - $22,209	-277 Reduced 8.14%	3,124 $248,000
Q1 2021 May 17, 2021	BUY	$53.79 - $66.98 $182,939 - $227,798	3,401 New	3,401 $223,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.